These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37835428)

  • 1. Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma.
    Alchahin AM; Tsea I; Baryawno N
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
    Gong Q; Jiang Y; Xiong J; Liu F; Guan J
    Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.
    Saout JR; Lecuyer G; Léonard S; Evrard B; Kammerer-Jacquet SF; Noël L; Khene ZE; Mathieu R; Brunot A; Rolland AD; Bensalah K; Rioux-Leclercq N; Lardenois A; Chalmel F
    Eur Urol; 2023 May; 83(5):441-451. PubMed ID: 36801089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction.
    Wu Y; Li X
    Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome Profiling Reveals B-Lineage Cells Contribute to the Poor Prognosis and Metastasis of Clear Cell Renal Cell Carcinoma.
    Yang F; Zhao J; Luo X; Li T; Wang Z; Wei Q; Lu H; Meng Y; Cai K; Lu L; Lu Y; Chen L; Sooranna SR; Luo L; Song J; Meng L
    Front Oncol; 2021; 11():731896. PubMed ID: 34485161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8
    Lu T; Zhang J; Lu S; Yang F; Gan L; Wu X; Song H; Liu S; Xu C; Han D; Yang B; Wen W; Qin W; Yang L
    Cancer Immunol Immunother; 2023 Jun; 72(6):1739-1750. PubMed ID: 36646951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal enhanced CT images reveal the tandem mechanism between tumor cells and immunocytes based on bulk/single-cell RNA sequencing.
    Liang H; Wu K; Wu R; Huang K; Deng Z; Chen H
    Funct Integr Genomics; 2023 Mar; 23(2):88. PubMed ID: 36933049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of lower mitochondrial complex I expression is associated with cell metastasis of clear cell renal cell carcinoma.
    Zhang F; Hou T; Chen L; Xiong M; Zhou M; Kazobinka G; Zhao J; Han X
    Transl Cancer Res; 2022 Jun; 11(6):1488-1502. PubMed ID: 35836523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
    Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma.
    Yu Z; Lv Y; Su C; Lu W; Zhang R; Li J; Guo B; Yan H; Liu D; Yang Z; Mi H; Mo L; Guo Y; Feng W; Xu H; Peng W; Cheng J; Nan A; Mo Z
    Cancer Res; 2023 Mar; 83(5):700-719. PubMed ID: 36607615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.
    Davidson G; Helleux A; Vano YA; Lindner V; Fattori A; Cerciat M; Elaidi RT; Verkarre V; Sun CM; Chevreau C; Bennamoun M; Lang H; Tricard T; Fridman WH; Sautes-Fridman C; Su X; Plassard D; Keime C; Thibault-Carpentier C; Barthelemy P; Oudard SM; Davidson I; Malouf GG
    Cancer Res; 2023 Sep; 83(17):2952-2969. PubMed ID: 37335139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma.
    Lin MJ; Tang XX; Yao GS; Tan ZP; Dai L; Wang YH; Zhu JQ; Xu QH; Mumin MA; Liang H; Wang Z; Deng Q; Luo JH; Wei JH; Cao JZ
    Front Pharmacol; 2023; 14():1120562. PubMed ID: 37021054
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular milieu in clear cell renal cell carcinoma.
    Raghubar AM; Roberts MJ; Wood S; Healy HG; Kassianos AJ; Mallett AJ
    Front Oncol; 2022; 12():943583. PubMed ID: 36313721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA-sequencing analysis reveals MYH9 promotes renal cell carcinoma development and sunitinib resistance via AKT signaling pathway.
    Xu Z; Liu M; Wang J; Liu K; Xu L; Fan D; Zhang H; Hu W; Wei D; Wang J
    Cell Death Discov; 2022 Mar; 8(1):125. PubMed ID: 35318312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease.
    Lakshminarayanan H; Rutishauser D; Schraml P; Moch H; Bolck HA
    Front Oncol; 2020; 10():582843. PubMed ID: 33194717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma.
    Chakiryan NH; Hajiran A; Kim Y; Aydin AM; Zemp L; Katende E; Nguyen J; Fan W; Cheng CH; Lopez-Blanco N; Chahoud J; Spiess PE; Fournier M; Dhillon J; Wang L; Moran-Segura C; Mulé J; Du D; Yoder SJ; Berglund A; Teer JK; Manley BJ
    Eur Urol Focus; 2022 May; 8(3):784-793. PubMed ID: 33994165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
    Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
    J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.